Skip to main content
Tessa NewsLink
Paste a health news link, or browse

Source study found

Story checked

Is Vitamin D3 Superior to D2? (opens in a new tab)

medscape.com · 2022-02-25

Short answerEvidenceSource

Short answer

Mixed

Mixed.

2 claims go further than the study. One other point was not covered by the paper.

  • 2 supported
  • 2 overstated
  • 1 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Mixed

Two of five claims overstate the study. Two of five check out. One claim the study doesn't address.

  • 2 supported
  • 2 overstated
  • 1 not covered
Open claim evidence
3
Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

5 claims in this story

Showing all 5 claimsChoose a verdict to focus the list.

Claim 1 of 5OverstatedResearchers from the Universities of Surrey and Brighton say vitamin D3 is superior to vitamin D2 in health effects and should be the favoured form for fortified foods and supplements.View evidenceHide evidence

As statedsuperior

Why this verdict

The paper profile supports that vitamin D2 and D3 had partly distinct effects on blood gene expression and immune-related transcriptomic signatures, including D3-specific interferon-associated stimulation. However, the abstract-level profile does not support the broader headline framing that D3 is 'superior' in overall health effects or that it 'should' be favored for fortified foods and supplements. That recommendation/health-superiority framing outruns both the molecular evidence and the more cautious body framing.

1

Study evidence

Supplementation with physiological daily doses of vitamin D2 or D3 over 12 weeks produced changes in the whole-blood transcriptome; while some differentially expressed genes overlapped between D2 and D3, most changes were specific to one vitamin.

“extends a previously published randomized placebo-controlled trial”
2

Study evidence

Vitamin D3 supplementation was associated predominantly with down-regulation of genes annotated to innate and adaptive immune system pathways, interpreted as a potential shift toward a more tolerogenic immune status.

“majority of changes in gene expression reflected a down-regulation... many encoding pathways of the innate and adaptive immune systems”
Claim 2 of 5OverstatedThe authors say vitamin D3 may help shift the immune system toward a more tolerogenic status and may help prevent viruses and bacteria from gaining a foothold in the body, but they also describe the findings as preliminary and needing independent verification.View evidenceHide evidence

Why this verdict

The profile supports the authors' interpretation that D3-related immune-pathway down-regulation may indicate a more tolerogenic status, and it supports D3-specific stimulation of interferon-associated transcriptomic signatures. But saying D3 may help prevent viruses and bacteria from gaining a foothold moves beyond the abstract-level evidence, which reports gene-expression signatures rather than demonstrated infection prevention or functional antimicrobial outcomes. The preliminary/verification caveat is directionally consistent with the paper's limitations, but it does not fully neutralize the clinical-health implication.

1

Study evidence

Vitamin D3 supplementation was associated predominantly with down-regulation of genes annotated to innate and adaptive immune system pathways, interpreted as a potential shift toward a more tolerogenic immune status.

“majority of changes in gene expression reflected a down-regulation... many encoding pathways of the innate and adaptive immune systems”
Claim 3 of 5Not coveredThe study included 97 participants selected for transcriptome analysis from a previous randomized comparison of 15 μg (600 IU) vitamin D2, 15 μg vitamin D3, or placebo daily for 12 weeks during UK winter.View evidenceHide evidence

As stated97 participants

Why this verdict

The abstract-level profile supports the trial structure, wintertime 12-week supplementation, 15 µg/day vitamin D2 or D3, placebo arm, and transcriptome analysis. But the exact statement that 97 participants were selected for transcriptome analysis is not available in the abstract-level profile, which explicitly lacks sample-size detail.

1

Study evidence

Supplementation with physiological daily doses of vitamin D2 or D3 over 12 weeks produced changes in the whole-blood transcriptome; while some differentially expressed genes overlapped between D2 and D3, most changes were specific to one vitamin.

“extends a previously published randomized placebo-controlled trial”
Claim 4 of 5SupportedThe study, published in Frontiers in Immunology, investigated the effect of vitamin D2 and vitamin D3 supplementation on the activity of human genes.View evidenceHide evidence

Why this verdict

The profile directly states that the study investigated how daily vitamin D2 versus vitamin D3 supplementation changed the human blood transcriptome/gene expression in a randomized placebo-controlled setting.

1

Study evidence

Supplementation with physiological daily doses of vitamin D2 or D3 over 12 weeks produced changes in the whole-blood transcriptome; while some differentially expressed genes overlapped between D2 and D3, most changes were specific to one vitamin.

“extends a previously published randomized placebo-controlled trial”
Claim 5 of 5SupportedThe article says gene expression related to type I and type II interferon activity differed after vitamin D2 and vitamin D3 supplementation, with only vitamin D3 having a stimulatory effect.View evidenceHide evidence

Why this verdict

The profile specifically reports that type I and type II interferon-associated gene expression differed after D2 versus D3 supplementation and that only vitamin D3 showed a stimulatory effect on interferon-associated expression.

1

Study evidence

Vitamin D3 supplementation was associated predominantly with down-regulation of genes annotated to innate and adaptive immune system pathways, interpreted as a potential shift toward a more tolerogenic immune status.

“majority of changes in gene expression reflected a down-regulation... many encoding pathways of the innate and adaptive immune systems”
Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

  • Pathway and interferon conclusions are inferential from blood microarray signatures and do not directly demonstrate functional immune tolerance, protein-level interferon activity, or clinical infection outcomes.

    Although the story includes preliminary and low-power caveats, it still translates transcriptomic signatures into possible prevention of viruses and bacteria gaining a foothold without clearly stating that these are not demonstrated functional or clinical outcomes.

    From Pathway/module-level analysis of microarray differential expression

6 things the story did carry across
  • Randomized placebo-controlled human supplementation study comparing 15 µg/day vitamin D2, 15 µg/day vitamin D3, and placebo over 12 weeks during UK winter, with blood transcriptome profiling at baseline and endpoint.
  • The central finding is molecular/transcriptomic non-equivalence: D2 and D3 produced overlapping but largely distinct blood gene-expression changes.
  • Vitamin D3 was associated with down-regulation of many innate and adaptive immune-pathway genes, interpreted as a possible shift toward a more tolerogenic immune profile.
  • Type I and type II interferon-associated gene expression differed between D2 and D3, with only D3 showing a stimulatory effect.
  • Possible ethnic differences in transcriptomic response between white European and South Asian women were noted, but abstract-level evidence provides no quantitative subgroup detail.
  • Important statistical and methodological details are absent at abstract depth, including effect sizes, sample sizes per arm, gene lists, pathway statistics, microarray processing, and multiple-testing correction.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

3

Evidence read

study summary

Lead result

human in vivo

1Lead resulthuman in vivoDetermine and compare how daily physiological-dose vitamin D2 vs vitamin D3 supplementation over 12 weeks changes the human blood transcriptome (within-individual baseline-to-endpoint changes) in a randomized placebo-controlled setting.Randomized placebo-controlled supplementation; longitudinal within-subject microarray analysisExpand

In plain English

Extension of a previously published randomized, placebo-controlled supplementation trial in healthy white European and South Asian women who received 15 µg/day vitamin D2 or D3 (or placebo) for 12 weeks in winter; whole-blood gene expression was measured by microarrays at baseline and 12 weeks and analyzed primarily as within-individual (paired) baseline-to-endpoint changes to compare transcriptomic effects of D2 versus D3.

Key findings

  • Supplementation with physiological daily doses of vitamin D2 or D3 over 12 weeks produced changes in the whole-blood transcriptome; while some differentially expressed genes overlapped between D2 and D3, most changes were specific to one vitamin.
  • Vitamin D3 supplementation predominantly down-regulated expression of many genes encoding innate and adaptive immune pathways, interpreted as potentially shifting the immune system toward a more tolerogenic status.
“extends a previously published randomized placebo-controlled trial”
What this piece can’t prove

4 further details could not be confirmed from the summary.

2human in vivoAssess whether transcriptomic responses to vitamin D2 vs D3 supplementation differ by ethnic background (white European vs South Asian women).ethnicity-stratified / interaction analysis within randomized supplementation trialExpand

In plain English

Within a randomized supplementation trial of healthy white European and South Asian women, the authors report that integrated transcriptome analyses indicated a possibility of ethnic differences in blood gene-expression responses to vitamin D2 versus D3 over 12 weeks, but the abstract provides no quantitative or locus-specific detail about those differences.

Key findings

  • The authors report that the data indicated a possibility of ethnic differences in transcriptomic responses to vitamin D2 versus D3 between white European and South Asian women.
“recruited healthy white European and South Asian women”
What this piece can’t prove
  • Abstract provides only a qualitative statement about ethnic differences without reporting significance, directionality, or magnitude.

2 further details could not be confirmed from the summary.

3human in vivoCharacterize immune-pathway-level implications of observed transcriptomic changes (e.g., innate/adaptive immune pathways, interferon-related signatures) following D2 vs D3 supplementation.Pathway/module-level analysis of microarray differential expressionExpand

In plain English

Pathway- and module-level analysis of blood microarray data from a 12-week supplementation trial indicates that vitamin D3 and D2 produce overlapping but largely distinct effects on immune-related gene expression. Vitamin D3 supplementation was associated predominantly with down-regulation of genes annotated to innate and adaptive immune pathways, a pattern interpreted by the authors as a shift toward a more tolerogenic immune status. Interferon-related signatures (type I and type II) differed between the vitamins: only vitamin D3 produced a stimulatory effect on interferon-associated gene expression according to the reported analyses. Some differences by ethnic group were noted as possible.

Key findings

  • Vitamin D3 supplementation was associated predominantly with down-regulation of genes annotated to innate and adaptive immune system pathways, interpreted as a potential shift toward a more tolerogenic immune status.
  • Interferon-related gene expression signatures (type I and type II) differed between the vitamins, with only vitamin D3 reported to have a stimulatory effect on interferon-associated expression.
“majority of changes in gene expression reflected a down-regulation... many encoding pathways of the innate and adaptive immune systems”
What this piece can’t prove
  • Pathway-level interpretations are inferential and may not reflect functional immune changes; transcriptome changes in blood may not represent tissue-specific immune activity.
  • Population studied was limited to trial participants (healthy white European and South Asian women in the UK); abstract does not provide sample sizes or power for subgroup (ethnicity) analyses.

2 further details could not be confirmed from the summary.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Papers considered

The selected paper, plus nearby candidates.

PubMed, Crossref, Europe PMC · 15 candidate papers

Candidate

Vitamin D3 Supplementation Does Not Improve Fracture Healing: An Exploratory Phase II Randomized Controlled Trial

OrthoMedia · 2022 · Crossref

Source (opens in a new tab)
Candidate

05 / Mechanisms of action for the biological differences in vitamin D2 and vitamin D3: further analysis of the D2-D3 study cohort

2018 · Crossref

Source (opens in a new tab)

And 9 more candidates considered.